On June 17 (local time), the Korea Exchange promoted the Korean capital market to executives and employees of global bio companies in Boston, USA, where "BIO USA 2025" was being held.
At the "Korea Capital Market Spotlight" event, which was organized for promotional purposes, the Korea Exchange, together with Invest Seoul, provided information to approximately 200 participants on the KOSDAQ listing process for foreign companies, the value-up program, and introduced various support policies. Domestic IPO (Initial Public Offering) specialist institutions gave presentations on trends in Korean venture capital (VC) investment, analysis of IPO cases, and legal and accounting issues related to listings.
"BIO USA 2025" is the world's largest exhibition in the bio and pharmaceutical sectors, with about 19,000 participants from 68 countries last year. The Korea Exchange held one-on-one meetings with foreign bio companies participating in the event to provide guidance on KOSDAQ market trends and listing procedures.
In his welcoming remarks at the "Korea Capital Market Spotlight," Korea Exchange Vice President Min Kyungwook explained the KOSDAQ market and the corporate value-up program, stating, "The Korea Exchange will continue to encourage interest in KOSDAQ listings and provide institutional support so that success stories of domestic and global bio innovation companies can continue."
The Korea Exchange plans to continue its efforts to promote the Korean capital market and to facilitate the listing of global companies in Korea.
Minkyung Wook, Head of the KOSDAQ Market Division at Korea Exchange, is delivering a greeting ahead of the "Korea Capital Market Spotlight" event held in Boston, USA, on the 17th (local time). Korea Exchange
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
